北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 期刊论文
学科主题: 临床医学
题名:
A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation
作者: Lin, San-Ren1; Ke, Mei-Yun1; Luo, Jin-Yan1; Yuan, Yao-Zong1; Wang, Ji-Yao1; diTommaso, Shelley1; Walter, Verena1; Huang, Jiaqing1
关键词: chronic constipation ; tegaserod ; China ; complete spontaneous bowel movement ; placebo-controlled ; stool
刊名: WORLD JOURNAL OF GASTROENTEROLOGY
发表日期: 2007-02-07
卷: 13, 期:5, 页:732-739
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Gastroenterology & Hepatology
研究领域[WOS]: Gastroenterology & Hepatology
关键词[WOS]: IRRITABLE-BOWEL-SYNDROME ; MANAGEMENT ; SYMPTOMS ; TRANSIT
英文摘要:

AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d..), in men and women with chronic constipation (CC) from China.

METHODS: This was a multicenter, double-blind, placebo-controlled study. Following a 2-wk treatmentfree baseline period, patients were randomized to receive either tegaserod (6 mg b.i.d.) or placebo (b.i.d.) for 4 wk. An analysis of covariance with repeated measures was used to determine the overall effect of treatment for the primary efficacy variable; the change from baseline in the number of complete spontaneous bowel movements (CSBMs) during the 4-wk treatment period. Secondary efficacy endpoints included other measures of response in terms of CSBMs, and patients′ daily and weekly assessment of bowel habits. Safety was also assessed, based on the incidence and severity of adverse events (AEs).

RESULTS: A total of 607 patients were randomized to receive either tegaserod (n = 304) or placebo (n = 303). Tegaserod treatment resulted in a rapid and significant increase from baseline in the adjusted mean, number of CSBMs per week over wk 1-4 compared with placebo (1.39 vs 0.91, P = 0.0002). A statistically significant difference in favor of tegaserod was also observed for a mean increase >= 1 CSBM/wk over wk 1-4 (47.7% vs 35.0%, tegaserod vs placebo, respectively, P = 0.0018) and for the absolute number of >= 3 CSBMs/wk over wk 1-4 (25.0% vs 14.5%, tegaserod vs placebo, respectively, P = 0.0021). Improvements in other symptoms of CC were also seen in the tegaserod group, including improved stool form and reduced straining. In addition, more patients in the tegaserod group reported satisfactory relief from their constipation symptoms. The frequency and severity of AEs was comparable between tegaserod and placebo groups, with the exception of a greater incidence of diarrhea in patients receiving tegaserod (3.6%) compared with placebo (1.7%).

CONCLUSION: Tegaserod treatment improved multiple symptoms of CC and was associated with a favorable safety profile. (c) 2007 The WJG Press. All rights reserved.

语种: 英语
WOS记录号: WOS:000244087400010
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/52097
Appears in Collections:北京大学第三临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Shanghai Zhongshan Hosp, Shanghai, Peoples R China
2.Novartis Pharma AG, Basel, Switzerland
3.Shanghai Ruijin Hosp, Shanghai, Peoples R China
4.Beijing Med Univ, Hosp 3, Beijing 100083, Peoples R China
5.Xian Jiaotong Univ, Hosp 2, Shanxi, Peoples R China
6.Novartis Pharmaceut Corp, Gastroenterol Urol Therapeut Area, Clin Dev & Med Affairs, E Hanover, NJ 07936 USA
7.Beijing Union Med Coll Hosp, Beijing, Peoples R China

Recommended Citation:
Lin, San-Ren,Ke, Mei-Yun,Luo, Jin-Yan,et al. A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation[J]. WORLD JOURNAL OF GASTROENTEROLOGY,2007,13(5):732-739.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Lin, San-Ren]'s Articles
[Ke, Mei-Yun]'s Articles
[Luo, Jin-Yan]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Lin, San-Ren]‘s Articles
[Ke, Mei-Yun]‘s Articles
[Luo, Jin-Yan]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
 *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace